BEYOND THE MONEY

This session will explore the benefits of raising Corporate VC and how it yields important dividends that are "beyond the bottom line," both for the investor and for the startup firm.

David C. Tharp
Vice-Consul & USA Lead Officer
UK Trade & Investment
British Consulate-General

Panelists:

Paul Cummings
Principal
Honda Strategic Venturing

Rajeev Dadoo, Ph.D.
Principal
SR One

Mathew George, CFA
Vice President
TELUS Ventures

Julie Gerstenberger
Director, External Alliances
Kodak Ventures

David Nanto
Director of Venture Development
NEC Corporation of America

Ira Nydick
Senior Technology Analyst
Panasonic Venture Group

Lauren Silverman, Ph.D.
Managing Director
Novartis BioVentures

INVESTING IN OUTSIDE INNOVATION: WHAT ARE CORPORATE VCs LOOKING TO FUND AND UNDER WHAT CONDITIONS?

Just as all companies have different strategic goals and interests, so to their Corporate VC divisions have highly varied strategies and approaches. Still, all involve some balance or mix of strategic corporate goals and financial ROI. This session will explore why certain deals and ventures have been historically of interest to corporate VC's and how this is playing out in the current market space.

Panelists:

Tara D. Butler, M.D.
Investment Director
Ascension Health Ventures

Dan Keoppel
Executive Director, Strategic Investments
Verizon Communications

Jeffrey B. Moore
Vice President
MP Healthcare Venture Management

Jim Peters
Partner
Geisinger Ventures

Jennifer Scholze
Partner
SAP Ventures

Tom Whiteaker
AVP
Hartford Ventures

Kuk Yi
Managing Partner
Best Buy Capital

BUILDING THE BRIDGE – CORPORATE & TRADITIONAL CAPITAL

While close to 20% of all venture-backed firms have corporate VC’s on board, it is unusual for a venture to be backed by corporate VC alone. When other investors are required corporate VC interests must be balanced with those of other investors, while at the same time ensuring that the venture moves forward and remains robust. This session will examine these different pieces to the Corporate Venture puzzle and how to best leverage the roles of all players involved.

Jim Sanger
General Partner
ABS Ventures

Panelists:

Patrick Chung
Managing Director
SK Telecom Ventures

Andrew T. Jay
Managing Partner
Siemens Venture Capital

Stephen Knight, M.D.
Managing Partner
Fidelity BioSciences

Charles R. Lax
Managing General Partner
GrandBanks Capital

Lucy Mcquilken
Director
Intel Capital

Dave Schulte
Principal
Kaiser Permanente Ventures

Spencer Tall
Managing Director
Allegis Capital